Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.

Abstract:

:Treatment outcomes for older patients with acute myeloid leukemia (AML) have remained dismal. This randomized, phase 2 trial in AML patients not considered suitable for intensive induction therapy compared low-dose cytarabine (LDAC) with or without volasertib, a highly potent and selective inhibitor of polo-like kinases. Eighty-seven patients (median age 75 years) received LDAC 20 mg twice daily subcutaneously days 1-10 or LDAC + volasertib 350 mg IV days 1 + 15 every 4 weeks. Response rate (complete remission and complete remission with incomplete blood count recovery) was higher for LDAC + volasertib vs LDAC (31.0% vs 13.3%; odds ratio, 2.91; P = .052). Responses in the LDAC + volasertib arm were observed across all genetic groups, including 5 of 14 patients with adverse cytogenetics. Median event-free survival was significantly prolonged by LDAC + volasertib compared with LDAC (5.6 vs 2.3 months; hazard ratio, 0.57; 95% confidence interval, 0.35-0.92; P = .021); median overall survival was 8.0 vs 5.2 months, respectively (hazard ratio, 0.63; 95% confidence interval, 0.40-1.00; P = .047). LDAC + volasertib led to an increased frequency of adverse events that was most pronounced for neutropenic fever/infections and gastrointestinal events; there was no increase in the death rate at days 60 + 90. This study was registered at www.clinicaltrials.gov as #NCT00804856.

journal_name

Blood

journal_title

Blood

authors

Döhner H,Lübbert M,Fiedler W,Fouillard L,Haaland A,Brandwein JM,Lepretre S,Reman O,Turlure P,Ottmann OG,Müller-Tidow C,Krämer A,Raffoux E,Döhner K,Schlenk RF,Voss F,Taube T,Fritsch H,Maertens J

doi

10.1182/blood-2014-03-560557

subject

Has Abstract

pub_date

2014-08-28 00:00:00

pages

1426-33

issue

9

eissn

0006-4971

issn

1528-0020

pii

blood-2014-03-560557

journal_volume

124

pub_type

杂志文章,多中心研究,随机对照试验

相关文献

BLOOD文献大全
  • Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura.

    abstract::Twenty-one human immunodeficiency virus (HIV)-positive patients, including 11 acquired immunodeficiency syndrome (AIDS)-free patients with immune thrombocytopenic purpura (ITP), were studied to determine whether the megakaryocytic/platelet lineage was infected by HIV. Because purification of platelets did not reach a ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Louache F,Bettaieb A,Henri A,Oksenhendler E,Farcet JP,Bierling P,Seligmann M,Vainchenker W

    更新日期:1991-10-01 00:00:00

  • Normal human serum contains natural antibodies reactive with autologous ABO blood group antigens.

    abstract::It is widely accepted that the serum of healthy individuals contains natural antibodies only against those blood group A or B antigens that are not expressed on the individual's red blood cells. The mechanisms involved in tolerance to autologous blood group antigens remain unclear. In the present study, we show that I...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Spalter SH,Kaveri SV,Bonnin E,Mani JC,Cartron JP,Kazatchkine MD

    更新日期:1999-06-15 00:00:00

  • Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer.

    abstract::A 64-yr-old female developed acute myeloblastic leukemia following radiation and drug therapy for colon carcinoma. The patient was heterozygous for glucose-6-phosphate dehydrogenase (G-6-PD) and displayed types A and B isoenzymes in nonhematopoietic tissue. In contrast, only type B G-6-PD was observed in peripheral bl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wiggans RG,Jacobson RJ,Fialkow PJ,Woolley PV 3rd,Macdonald JS,Schein PS

    更新日期:1978-10-01 00:00:00

  • Genetic evidence for an additional factor required for erythropoietin-induced signal transduction.

    abstract::Erythropoietin (EPO) and its receptor (EPOR) are required for the development of mature erythrocytes. After binding of ligand, the EPOR activates a variety of signaling pathways that ultimately control cellular proliferation, survival, and specific gene expression. Although erythroid progenitors appear to be the princ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gaffen SL,Lai SY,Longmore GD,Liu KD,Goldsmith MA

    更新日期:1999-07-01 00:00:00

  • Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia.

    abstract::To elucidate the role of thrombocytosis, alone or in combination with standard (age, previous cardiovascular events) and novel (leukocytosis, JAK2(V617F) mutational status) risk factors, in the cardiovascular events of essential thrombocythemia (ET), we analyzed a cohort of 1063 patients. We found that a platelet coun...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-153783

    authors: Carobbio A,Finazzi G,Antonioli E,Guglielmelli P,Vannucchi AM,Delaini F,Guerini V,Ruggeri M,Rodeghiero F,Rambaldi A,Barbui T

    更新日期:2008-10-15 00:00:00

  • A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.

    abstract::Chronic lymphocytic leukemia (CLL) is an incurable adult disease of unknown etiology. Understanding the biology of CLL cells, particularly cell maturation and growth in vivo, has been impeded by lack of a reproducible adoptive transfer model. We report a simple, reproducible system in which primary CLL cells prolifera...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-324210

    authors: Bagnara D,Kaufman MS,Calissano C,Marsilio S,Patten PE,Simone R,Chum P,Yan XJ,Allen SL,Kolitz JE,Baskar S,Rader C,Mellstedt H,Rabbani H,Lee A,Gregersen PK,Rai KR,Chiorazzi N

    更新日期:2011-05-19 00:00:00

  • Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma.

    abstract::Thalidomide (Thal) can overcome drug resistance in multiple myeloma (MM) but is associated with somnolence, constipation, and neuropathy. In previous in vitro studies, we have shown that the potent immunomodulatory derivative of thalidomide (IMiD) CC-5013 induces apoptosis or growth arrest even in resistant MM cell li...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-03-0996

    authors: Richardson PG,Schlossman RL,Weller E,Hideshima T,Mitsiades C,Davies F,LeBlanc R,Catley LP,Doss D,Kelly K,McKenney M,Mechlowicz J,Freeman A,Deocampo R,Rich R,Ryoo JJ,Chauhan D,Balinski K,Zeldis J,Anderson KC

    更新日期:2002-11-01 00:00:00

  • Interleukin-3 treatment of rhesus monkeys leads to increased production of histamine-releasing cells that express interleukin-3 receptors at high levels.

    abstract::To understand the hematopoietic and nonhematopoietic responses to interleukin-3 (IL-3), expression of cell-surface IL-3 receptors (IL-3R) was examined on bone marrow (BM) cells and peripheral blood (PB) cells of rhesus monkeys during the course of in vivo IL-3 treatment. Whereas IL-3R expression is low in untreated mo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Gils FC,van Teeffelen ME,Neelis KJ,Hendrikx J,Burger H,van Leen RW,Knol E,Wagemaker G,Wognum AW

    更新日期:1995-07-15 00:00:00

  • Hepatosplenic candidiasis--a contraindication to marrow transplantation?

    abstract::To determine whether a prior history of hepatosplenic candidiasis resulted in increased Candida-associated morbidity and mortality after marrow transplant, 15 consecutive patients with biopsy-proven hepatosplenic candidiasis were observed prospectively. All patients received amphotericin B before transplant. Amphoteri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bjerke JW,Meyers JD,Bowden RA

    更新日期:1994-10-15 00:00:00

  • Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.

    abstract::Peripheral blood stem cells (PBSCs) are widely used in autologous transplantation because of ease of collection and rapid hematopoietic reconstitution. However, PBSCs have rarely been used for allogeneic transplantation because of concerns about donor toxicities from cytokine administration and the theoretical increas...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bensinger WI,Weaver CH,Appelbaum FR,Rowley S,Demirer T,Sanders J,Storb R,Buckner CD

    更新日期:1995-03-15 00:00:00

  • Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease.

    abstract::Transfusion-associated graft-versus-host disease can be prevented by treating cellular blood products with gamma irradiation. A wide range of gamma irradiation dose levels has been used in routine practice. We used limiting dilution analysis, which measures clonable T cells, to assess the influence of 500 to 3,000 cGy...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pelszynski MM,Moroff G,Luban NL,Taylor BJ,Quinones RR

    更新日期:1994-03-15 00:00:00

  • Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice.

    abstract::Until recently, IgE-activated mast cells have been regarded merely as effector cells of adaptive immune responses, involved in allergic reactions and mucosal immunity to parasites. Herein, we report that murine dermal mast cells, activated by local administration of a cream containing the synthetic TLR7 ligand imiquim...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-036889

    authors: Heib V,Becker M,Warger T,Rechtsteiner G,Tertilt C,Klein M,Bopp T,Taube C,Schild H,Schmitt E,Stassen M

    更新日期:2007-08-01 00:00:00

  • Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53.

    abstract::Human T-cell leukemia virus type-I (HTLV-I), the etiologic agent of adult T-cell leukemia (ATL) transforms human T cells both in vivo and in vitro. However, the long latency period between infection and development of ATL, as well as the small fraction of the infected population that actually develops this disease, su...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mori N,Kashanchi F,Prager D

    更新日期:1997-12-15 00:00:00

  • Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein.

    abstract::It has previously been shown that human granulocyte-macrophage colony-stimulating factor (GM-CSF) can be fused to a truncated diphtheria toxin (DT) to produce a recombinant fusion toxin that kills GM-CSF receptor-bearing cells. We now report that DT388-GM-CSF induces apoptosis and inhibition of colony formation in sem...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Frankel AE,Hall PD,Burbage C,Vesely J,Willingham M,Bhalla K,Kreitman RJ

    更新日期:1997-11-01 00:00:00

  • Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development.

    abstract::Mice deficient in c-fms-like tyrosine kinase 3 (FLT3) signaling have reductions in early multipotent and lymphoid progenitors, whereas no evident myeloid phenotype has been reported. However, activating mutations of Flt3 are among the most common genetic events in acute myeloid leukemia and mice harboring internal tan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-258756

    authors: Böiers C,Buza-Vidas N,Jensen CT,Pronk CJ,Kharazi S,Wittmann L,Sitnicka E,Hultquist A,Jacobsen SE

    更新日期:2010-06-17 00:00:00

  • Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.

    abstract::Expression of vascular endothelial growth factor (VEGF) is tightly regulated to achieve normal angiogenesis. The objective was to examine regulation of VEGF by the activin-like kinase receptors (ALKs) ALK1 and ALK5. Transforming growth factor beta1 (TGFbeta1) and bone morphogenetic protein-9 (BMP-9) enhanced and suppr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-199166

    authors: Shao ES,Lin L,Yao Y,Boström KI

    更新日期:2009-09-03 00:00:00

  • Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia.

    abstract::Fifty-one children with acute lymphoblastic leukemia (ALL) in second or subsequent remission after a first remission of at least 24 months underwent purged, autologous bone marrow transplantation (ABMT). Bone marrow was harvested in remission and purged in vitro with monoclonal antibodies specific for leukemia-associa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Billett AL,Kornmehl E,Tarbell NJ,Weinstein HJ,Gelber RD,Ritz J,Sallan SE

    更新日期:1993-03-15 00:00:00

  • Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation.

    abstract::We prospectively evaluated 169 patients with a number of screening studies performed between 71 to 121 days after allogeneic marrow transplantation to detect the development of chronic graft-versus-host disease (GVHD). Group 1 patients (n = 78) were asymptomatic and had normal physical examinations at the time of scre...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Loughran TP Jr,Sullivan K,Morton T,Beckham C,Schubert M,Witherspoon R,Sale G,Sanders J,Fisher L,Shulman H

    更新日期:1990-07-01 00:00:00

  • Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.

    abstract::Peripheral T-cell lymphomas (PTCLs) are rare lymphomas with mostly poor outcome with current treatment. The addition of etoposide to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) and upfront consolidation with autologous stem cell transplantation (auto-SCT) have shown promising results but have nev...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-04-573089

    authors: Ellin F,Landström J,Jerkeman M,Relander T

    更新日期:2014-09-04 00:00:00

  • Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.

    abstract::Typical acute promyelocytic leukemia (APL) is associated with expression of the PML-RARalpha fusion protein and responsiveness to treatment with all-trans retinoic acid (ATRA). A rare, but recurrent, APL has been described that does not respond to ATRA treatment and is associated with a variant chromosomal translocati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guidez F,Ivins S,Zhu J,Söderström M,Waxman S,Zelent A

    更新日期:1998-04-15 00:00:00

  • Fibroblast growth factor controls the timing of Scl, Lmo2, and Runx1 expression during embryonic blood development.

    abstract::To program pluripotent cells into blood, a knowledge of the locations of precursors during their journey through the embryo and the signals they experience would be informative. The anterior (a) and posterior (p) ventral blood islands (VBIs) in Xenopus are derived from opposite sides of the pregastrula embryo. The aVB...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-081323

    authors: Walmsley M,Cleaver D,Patient R

    更新日期:2008-02-01 00:00:00

  • Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disea

    abstract::T cell-depleted haploidentical hematopoietic stem cell transplantation (haploHSCT) is an option to treat children with very high-risk acute lymphoblastic leukemia (ALL) lacking an HLA-identical donor. We analyzed 127 children with ALL who underwent haploHSCT in first (n = 22), second (n = 48), or third (n = 32), compl...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2009-03-207001

    authors: Klingebiel T,Cornish J,Labopin M,Locatelli F,Darbyshire P,Handgretinger R,Balduzzi A,Owoc-Lempach J,Fagioli F,Or R,Peters C,Aversa F,Polge E,Dini G,Rocha V,Pediatric Diseases and Acute Leukemia Working Parties of the Europe

    更新日期:2010-04-29 00:00:00

  • Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis.

    abstract::Pacritinib (SB1518) is a Janus kinase 2 (JAK2), JAK2(V617F), and Fms-like tyrosine kinase 3 inhibitor that does not inhibit JAK1. It demonstrated a favorable safety profile with promising efficacy in phase 1 studies in patients with primary and secondary myelofibrosis (MF). This multicenter phase 2 study further chara...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2013-02-484832

    authors: Komrokji RS,Seymour JF,Roberts AW,Wadleigh M,To LB,Scherber R,Turba E,Dorr A,Zhu J,Wang L,Granston T,Campbell MS,Mesa RA

    更新日期:2015-04-23 00:00:00

  • Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells.

    abstract::The transcription factor runt-related transcription factor 1 (Runx1) is essential for the establishment of definitive hematopoiesis during embryonic development. In adult blood homeostasis, Runx1 plays a pivotal role in the maturation of lymphocytes and megakaryocytes. Furthermore, Runx1 is required for the regulation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-09-382390

    authors: Ross K,Sedello AK,Todd GP,Paszkowski-Rogacz M,Bird AW,Ding L,Grinenko T,Behrens K,Hubner N,Mann M,Waskow C,Stocking C,Buchholz F

    更新日期:2012-05-03 00:00:00

  • Selective binding of the factor VIII/von Willebrand factor protein to human platelets.

    abstract::The factor VIII/von Willebrand factor protein was radiolabeled after modification by galactose oxidase and reduction with tritiated potassium borohydride. This mild efficient method for labeling resulted in retention of over 90% of the biologic activities of the factor VIII/von Willebrand factor protein. Binding of th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morisato DK,Gralnick HR

    更新日期:1980-01-01 00:00:00

  • The role of apoptosis in the development of AGM hematopoietic stem cells revealed by Bcl-2 overexpression.

    abstract::Apoptosis is an essential process in embryonic tissue remodeling and adult tissue homeostasis. Within the adult hematopoietic system, it allows for tight regulation of hematopoietic cell subsets. Previously, it was shown that B-cell leukemia 2 (Bcl-2) overexpression in the adult increases the viability and activity of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-06-1827

    authors: Orelio C,Harvey KN,Miles C,Oostendorp RA,van der Horn K,Dzierzak E

    更新日期:2004-06-01 00:00:00

  • Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.

    abstract::Overactivated complement is a high-risk feature in hematopoietic stem cell transplant (HSCT) recipients with transplant-associated thrombotic microangiopathy (TA-TMA), and untreated patients have dismal outcomes. We present our experience with 64 pediatric HSCT recipients who had high-risk TA-TMA (hrTA-TMA) and multio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004218

    authors: Jodele S,Dandoy CE,Lane A,Laskin BL,Teusink-Cross A,Myers KC,Wallace G,Nelson A,Bleesing J,Chima RS,Hirsch R,Ryan TD,Benoit S,Mizuno K,Warren M,Davies SM

    更新日期:2020-03-26 00:00:00

  • Cytologic characterization and significance of normal karyotypes in t(8;21) acute myeloblastic leukemia.

    abstract::A cytologic and cytogenetic study of 10 cases of acute myeloblastic leukemia with maturation and t(8;21) translocation is reported. Despite a certain polymorphic appearance, the characteristic cytologic picture, consisting essentially of large myeloblasts with an abundant cytoplasma containing a large Auer rod, allowe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Berger R,Bernheim A,Daniel MT,Valensi F,Sigaux F,Flandrin G

    更新日期:1982-01-01 00:00:00

  • VCAM-1 has a tissue-specific role in mediating interleukin-4-induced eosinophil accumulation in rat models: evidence for a dissociation between endothelial-cell VCAM-1 expression and a functional role in eosinophil migration.

    abstract::Eosinophil accumulation has been associated with the pathogenesis of numerous allergic inflammatory disorders. Despite the great interest in this response, many aspects of eosinophil accumulation remain unknown. This is particularly true with respect to tissue-specific mechanisms that may regulate the accumulation of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Larbi KY,Allen AR,Tam FW,Haskard DO,Lobb RR,Silva PM,Nourshargh S

    更新日期:2000-11-15 00:00:00

  • ALCAM (CD166): its role in hematopoietic and endothelial development.

    abstract::A critical role for the endothelium of yolk sac and dorsal aorta has been shown in embryonic hematopoiesis. A stromal cell line derived from yolk sac, YSCL-72, has been chosen to search for a novel molecule associated with embryonic hematopoiesis. Analysis between YSCL-72 and an adult aorta-derived endothelial cell li...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.7.2134

    authors: Ohneda O,Ohneda K,Arai F,Lee J,Miyamoto T,Fukushima Y,Dowbenko D,Lasky LA,Suda T

    更新日期:2001-10-01 00:00:00